Drug Shortage Report for CYTARABINE INJECTION
Report ID | 147647 |
Drug Identification Number | 02126656 |
Brand name | CYTARABINE INJECTION |
Common or Proper name | CYTARABINE INJECTION |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | CYTARABINE |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRATHECAL SUBCUTANEOUS INTRAVENOUS INTRATHECAL |
Packaging size | 1 x 20mL vial |
ATC code | L01BC |
ATC description | ANTIMETABOLITES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2021-10-20 |
Estimated end date | |
Actual end date | 2021-12-08 |
Shortage status | Resolved |
Updated date | 2021-12-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-12-09 | English | Compare |
v7 | 2021-12-08 | French | Compare |
v6 | 2021-12-08 | English | Compare |
v5 | 2021-11-03 | French | Compare |
v4 | 2021-11-03 | English | Compare |
v3 | 2021-10-21 | English | Compare |
v2 | 2021-10-20 | French | Compare |
v1 | 2021-10-20 | English | Compare |
Showing 1 to 8 of 8